DOW JONES27,589.08-371.72 -1.33%
S&P 5003,182.22-43.67 -1.35%
NASDAQ9,120.86-100.42 -1.09%

HC Wainwright & Co. Maintains Buy on Immunomedics, Raises Price Target to $31

HC Wainwright & Co. maintains Immunomedics (NASDAQ:IMMU) with a Buy and raises the price target from $26 to $31.

Benzinga · 12/27/2019 12:08

HC Wainwright & Co. maintains Immunomedics (NASDAQ:IMMU) with a Buy and raises the price target from $26 to $31.